Wouter H. van Geffen (Groningen, Netherlands), Maurizio Marvisi (Cremona, Italy)
LATE-BREAKING ABSTRACT: No relationship between cardiovascular morbidity and moderate-to-severe exacerbation rates in COPD patients in primary care
Paul Jones (London, United Kingdom), Paul Jones, Jadwiga Wedzicha, Alvar Agusti, Marc Decramer, Alice Raillard, Hana Müllerová, Chang-Qing Zhu, Lukasz Adamek
|   |
The serum level of surfactantproteind in patients with chronic obstructive pulmonary disease, depending on the nutrtional status
Anna Stupnytska (Chernivtsi, Ukraine), Ganna Stupnytska, Anastasiya Stupnytska, Olga Pritulyak, Olga Nesterovska
| |
Correlation between extracellular heat shock protein 72 and clinical parameters including exhaled oxygen level in COPD
Balázs Odler (Budapest, Hungary), Balazs Odler, Vivien Somogyi, Gabor Horvath, Veronika Müller
| |
Continuous indacaterol treatment improves autonomic cardiac regulation in COPD patients
Rustem Zulkarneev (Ufa, Republic of Bashkortostan, Russian Federation), Juliana Safina, Naufal Zagidullin, Rustem Zulkarneev, Diana Gareeva, Usman Farhutdinov, Shamil Zagidullin, Julia Aznabaeva
| |
Hypercapnea is associated with cardiac arrhythmias in COPD
Gunnar Einvik (Lørenskog, Norway), Gunnar Einvik, Rahul Bhatnagar, Nils Henrik Holmedahl, Anke Neukamm, Vidar Søyseth
| |
Marfanoid phenotype as a predictor of COPD formation in young patients
Anna Khomenya (Omsk, Russian Federation), Anna Khomenya, Maria Vershinina, Galina Nechaeva, Lev Grinberg
| |
Association between arterial stiffness and acute exacerbations in patients with chronic obstructive pulmonary disease
Esra Uzaslan (Bursa, Turkey), Sinem Ozbay Ozyilmaz, Isa Ozyilmaz, Osman Akin Serdar, Esra Uzaslan
| |
The median number of COPD exacerbations per year in patients with different polymorphisms of the gene ADRB2
Malika Mustafina (Moscow, Russian Federation), Malika Mustafina, Olga Tsvetkova, Eduard Generozov
| |
Increased total serum levels of ghrelin and nesfatin in chronic obstructive pulmonary disease
Ceylan Ayada (Kütahya, Turkey), Ceylan Ayada, Ümran Toru, Osman Genç, Server Sahin, Özlem Arik, Ismet Bulut
| |
Increased platelet reactivity during acute exacerbations of COPD, irrespective of antiplatelet therapy
Mariana Mercedes Munoz Esquerre (Castelldefels (Barcelona), Spain), Mariana Munoz-Esquerre, José Luis Ferreiro, Daniel Huertas, Ana L. Marcano, Marta López-Sánchez, Frederic Manresa, Joan Antoni Gómez-Hospital, Angel R. Cequier, Jordi Dorca, Salud Santos
| |
Angiographically objectified presence of coronary artery disease in patients with exacerbated chronic obstructive pulmonary disease and raised troponin I - The BEETHOVEN trial
Carmen Pizarro (Bonn, Germany), Carmen Pizarro, Neele Herweg-Steffens, Nikos Werner, Georg Nickenig, Dirk Skowasch
| |
Impact of not planned readmissions due to acute exacerbations of chronic obstructive pulmonary disease
Laura Rarmirez Garcia (Madrid, Spain), Laura Ramírez García, Milagros Llanos Flores, Alicia Oliva Ramos, Alicia Cerezo Lajas, Ingrid Frías Benzant, Rodrigo Jiménez García, Valentín Hernández Barrera, Pilar Carrasco Garrido, Ana López de Andrés, Luis Puente Maestu, Javier De Miguel Díez
| |
Clinical characteristics of patients with clinically-diagnosed COPD exacerbations but without concomitant airflow limitation
Sheila Zanoria (Farmington, United States of America), Sheila Zanoria, Richard ZuWallack, Bibek Singh Pannu
| |
Health status predicted mortality in hypercapnic patients with noninvasive ventilation
Toru Oga (Kyoto, Japan), Toru Oga, Hiroyuki Taniguchi, Hideo Kita, Tomomasa Tsuboi, Keisuke Tomii, Morihide Ando, Eiji Kojima, Hiromi Tomioka, Yoshio Taguchi, Yusuke Kaji, Ryoji Maekura, Toru Hiraga, Naoki Sakai, Tomoki Kimura, Michiaki Mishima, Kazuo Chin
| |
Health status predicts long-term outcomes in patients with chronic obstructive pulmonary disease (COPD): Pooled analysis of patient-level data from the COPD biomarker qualification consortium database
Hana Muellerova (Uxbridge, Middlesex, United Kingdom), Hana Müllerová, Heather Gelhorn, Hilary Wilson, Victoria Benson, Niklas Karlsson, Shailendra Menjoge, Debora Merrill, Stephen Rennard, Ruth Tal-Singer, Margaret Tabberer, Paul Jones
| |
Matrix metalloproteinase, hyaluronic acid and C-reactive protein: Are they really markers of lung obstruction at COPD but not cardiovascular comorbidity?
Bogdana Basina (Dnipropetrovsk, Ukraine), Bogdana Basina, Tetyana Pertseva, Lyudmila Konopkina
| |
Relationship between COPD characteristics and airway bacterial load measured using 16S qPCR
Simon Brill (London, United Kingdom), Simon E. Brill, Phillip James, William O.C. Cookson, Miriam F. Moffatt, Jadwiga A. Wedzicha
| |
A novel lung pharmacokinetic model predicts lung exposure and supports dose selection for clinical study of AZD2115, a dual muscarinic receptor antagonist/beta2 adrenoceptor agonist (MABA)
Ramon Hendrickx (Gothenburg, Sweden), Ramon Hendrickx, Ann Aurell Holmberg, Ulf Eriksson, Ken Grime
| |